Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 12 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Coffee cup stationery tab
Secure soft SIM credential transfer
Chip on film (COF) package having test line for testing electrical function of chip and method for manufacturing same
Method and an apparatus for processing an audio signal
Automated gate system
In-vehicle electronic control apparatus having monitoring control circuit
Illumination unit for a direct-view display
  Randomly Featured Patents
Top sizer for garment hanger
Hybrid vehicle driven by composit torque generated by an internal-combustion engine and an electric motor, and method of operating same
Method and device for driving a compaction machine
Substituted quinazolines and analogs and use thereof
Patterned oxygen and moisture absorber for organic optoelectronic device structures
Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity
Dynamic repair of redundant memory array
Waterborne composition for forming protective coatings
MOS transistor having a tensile-strained SI layer and a compressive-strained SI-GE layer
Case for croquet equipment